Aquestive Therapeutics (AQST) PT Lowered to $9 at BMO Capital
Tweet
Share
E-mailGet Alerts AQST Hot Sheet
Price: $4.32 +0.70%
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
BMO Capital analyst Gary Nachman lowered the price target on Aquestive Therapeutics (NASDAQ: AQST) to $9.00 (from $10.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Pony AI Inc (PONY) PT Lowered to $17 at BofA Securities
- Clean Energy Fuels (CLNE) PT Lowered to $2.50 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
